DE69229512D1 - Verfahren und Zusammensetzung mit Haloperoxydase zur Behandlung von Infektionen und Kontrolle der Flora - Google Patents

Verfahren und Zusammensetzung mit Haloperoxydase zur Behandlung von Infektionen und Kontrolle der Flora

Info

Publication number
DE69229512D1
DE69229512D1 DE69229512T DE69229512T DE69229512D1 DE 69229512 D1 DE69229512 D1 DE 69229512D1 DE 69229512 T DE69229512 T DE 69229512T DE 69229512 T DE69229512 T DE 69229512T DE 69229512 D1 DE69229512 D1 DE 69229512D1
Authority
DE
Germany
Prior art keywords
microbe
target
haloperoxidase
peroxide
halide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Revoked
Application number
DE69229512T
Other languages
English (en)
Other versions
DE69229512T2 (de
Inventor
Robert Charles Allen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Exoxemis Inc
Original Assignee
Exoxemis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24651753&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69229512(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Exoxemis Inc filed Critical Exoxemis Inc
Application granted granted Critical
Publication of DE69229512D1 publication Critical patent/DE69229512D1/de
Publication of DE69229512T2 publication Critical patent/DE69229512T2/de
Anticipated expiration legal-status Critical
Revoked legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/46Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/50Isolated enzymes; Isolated proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44Oxidoreductases (1)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L12/00Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
    • A61L12/08Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
    • A61L12/082Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances in combination with specific enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L12/00Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
    • A61L12/08Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
    • A61L12/12Non-macromolecular oxygen-containing compounds, e.g. hydrogen peroxide or ozone
    • A61L12/124Hydrogen peroxide; Peroxy compounds
    • A61L12/126Hydrogen peroxide; Peroxy compounds neutralised with catalase or peroxidase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/38Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A61L2300/254Enzymes, proenzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404Biocides, antimicrobial agents, antiseptic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pest Control & Pesticides (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Agronomy & Crop Science (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
DE69229512T 1991-02-21 1992-02-21 Verfahren und Zusammensetzung mit Haloperoxydase zur Behandlung von Infektionen und Kontrolle der Flora Revoked DE69229512T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US66099491A 1991-02-21 1991-02-21

Publications (2)

Publication Number Publication Date
DE69229512D1 true DE69229512D1 (de) 1999-08-12
DE69229512T2 DE69229512T2 (de) 2000-03-30

Family

ID=24651753

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69233698T Expired - Lifetime DE69233698T2 (de) 1991-02-21 1992-02-21 Haloperoxidase zur Behandlung von Infektionen und Kontrolle der Flora
DE69229512T Revoked DE69229512T2 (de) 1991-02-21 1992-02-21 Verfahren und Zusammensetzung mit Haloperoxydase zur Behandlung von Infektionen und Kontrolle der Flora

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69233698T Expired - Lifetime DE69233698T2 (de) 1991-02-21 1992-02-21 Haloperoxidase zur Behandlung von Infektionen und Kontrolle der Flora

Country Status (11)

Country Link
US (1) US6294168B1 (de)
EP (2) EP0923939B1 (de)
JP (2) JP4063317B2 (de)
KR (1) KR930703012A (de)
AT (2) ATE181837T1 (de)
AU (1) AU663869B2 (de)
CA (1) CA2061601C (de)
DE (2) DE69233698T2 (de)
IE (1) IE920514A1 (de)
IL (1) IL100997A (de)
WO (1) WO1992014484A1 (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5565197A (en) * 1991-02-21 1996-10-15 Exoxemis, Inc. Method which utilizes a haloperoxidase composition to inhibit the growth of microorganisms which cause sexually transmitted diseases
US5756090A (en) * 1991-02-21 1998-05-26 Eoe, Inc. Oxygen activatable formulations for disinfection or sterilization
WO1994023742A1 (en) * 1993-04-15 1994-10-27 Exoxemis, Inc. Methods and compositions for the prevention or treatment of sexually transmitted diseases
AU2085995A (en) * 1994-03-31 1995-10-23 Stichting Scheikundig Onderzoek In Nederland Antifouling paint containing haloperoxidases and method to determine halide concentrations
NL9401048A (nl) * 1994-03-31 1995-11-01 Stichting Scheikundig Onderzoe Haloperoxidasen.
DE4430327C1 (de) * 1994-08-27 1996-05-09 Degussa Enzymatische, aktiven Sauerstoff liefernde Mischung sowie Verfahren zur enzymatischen Herstellung von Persäuren
AU703034B2 (en) * 1995-10-25 1999-03-11 Eoe, Inc. Microporous pathogen-killing composition
WO1997042825A1 (en) * 1996-05-09 1997-11-20 Novo Nordisk A/S Antimicrobial peroxidase compositions
EP0849585A3 (de) * 1996-12-18 1998-09-02 Kabushiki Kaisha Egawa Vorrichtung zur Kontrolle der Funktion von Mikroben und Zellen, Verfahren zu deren Steuerung, sowie Vorrichtung zur Detektion einer mikrobischen Umgebung
AU6469698A (en) * 1997-03-24 1998-10-20 Clorox Company, The A chloroperoxidase enzyme system for generating hypochlorous acid and hypochlorite (in situ)
US6251386B1 (en) 1997-08-14 2001-06-26 Novo Nordisk A/S Antimicrobial composition containing a haloperoxidase, a hydrogen peroxide source, a halide source and an ammonium source
US6492110B1 (en) 1998-11-02 2002-12-10 Uab Research Foundation Reference clones and sequences for non-subtype B isolates of human immunodeficiency virus type 1
US6605751B1 (en) 1997-11-14 2003-08-12 Acrymed Silver-containing compositions, devices and methods for making
US7063970B1 (en) 1999-05-06 2006-06-20 Norozymes A/S Enzymatic preservation of water based paints
AU2742401A (en) 1999-12-30 2001-07-16 Acrymed Methods and compositions for improved delivery devices
CN1315523A (zh) * 2000-03-28 2001-10-03 上海博德基因开发有限公司 一种新的多肽——人过氧化酶18和编码这种多肽的多核苷酸
CN1315532A (zh) * 2000-03-29 2001-10-03 上海博德基因开发有限公司 一种新的多肽——人过氧化酶11和编码这种多肽的多核苷酸
WO2002047483A1 (en) * 2000-12-15 2002-06-20 Novozymes A/S Use of haloperoxidase, peroxide and carboxylic acid
US20040086453A1 (en) * 2001-01-22 2004-05-06 Howes Randolph M. Compositions, methods, apparatuses, and systems for singlet oxygen delivery
US20030118472A1 (en) * 2001-08-08 2003-06-26 Mckee Mary Mowrey Disinfecting and cleaning system for contact lenses
SE0200876L (sv) * 2002-03-22 2003-09-23 Krister Tano Nässpray mot öroninflammationer
US8361553B2 (en) 2004-07-30 2013-01-29 Kimberly-Clark Worldwide, Inc. Methods and compositions for metal nanoparticle treated surfaces
AU2005280443B2 (en) 2004-07-30 2011-02-03 Avent, Inc. Antimicrobial silver compositions
US10251392B2 (en) 2004-07-30 2019-04-09 Avent, Inc. Antimicrobial devices and compositions
EP1809264B1 (de) 2004-09-20 2016-04-13 Avent, Inc. Antimikrobielle amorphe zusammensetzungen
US20070264355A1 (en) * 2005-12-14 2007-11-15 Binary, Llc Binary compositions and methods for sterilization
WO2007127236A2 (en) 2006-04-28 2007-11-08 Acrymed, Inc. Antimicrobial site dressings
JP5558458B2 (ja) 2008-03-20 2014-07-23 タノメド・アクチボラゲット 普通感冒の治療用の医薬の製造における物質の使用
US8945540B2 (en) * 2008-05-09 2015-02-03 Exoxemis, Inc. Compositions for enhancing the antibacterial activity of myeloperoxidase and methods of use thereof
AU2012281172B2 (en) 2011-07-11 2016-11-17 Exoxemis, Inc. Eosinophil peroxidase compositions and methods of their use
EP2671449A1 (de) 2012-06-06 2013-12-11 Construction Research & Technology GmbH Verwendung von Vanadiumpentoxidpartikeln als Biozid
KR101434553B1 (ko) 2012-09-04 2014-08-26 녹십자수의약품(주) 어류의 스쿠티카충 및 병원성 세균 구제용 조성물 및 이들의 구제방법
US9814234B2 (en) 2014-01-14 2017-11-14 Exoxemis, Inc. Bioactive heme-haloperoxidase compositions and methods of their use
EP3245871A1 (de) 2014-04-30 2017-11-22 Matoke Holdings Limited Antimikrobielle zusammensetzungen
KR101647557B1 (ko) * 2014-10-23 2016-08-10 동아대학교 산학협력단 과산화수소를 포함하는 푸자리움 푸지쿠로이의 선택배지 및 이의 용도
CN109414485B (zh) * 2016-05-27 2022-08-12 埃欧艾米斯公司 用于抑制脂多糖和脂质a的髓过氧化物酶组合物和方法
DE102016120736A1 (de) 2016-10-31 2018-05-03 Johannes-Gutenberg-Universität Mainz Biozider Stoff und damit hergestellte Produkte
GB2566516A (en) 2017-09-15 2019-03-20 Univ Oxford Innovation Ltd Electrochemical recognition and quantification of cytochrome c oxidase expression in bacteria
GB201716986D0 (en) 2017-10-16 2017-11-29 Matoke Holdings Ltd Antimicrobial compositions
WO2020014493A1 (en) * 2018-07-13 2020-01-16 Allen Robert C Haloperoxidase compositions and uses thereof
GB2589863A (en) * 2019-12-09 2021-06-16 Institute Of Tech Sligo Antimicrobial composition
CN112259158B (zh) * 2020-09-16 2023-03-28 青岛蔚蓝生物股份有限公司 一种在食品热处理加工过程中益生菌存活量的预测模型

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2679533A (en) 1951-11-03 1954-05-25 California Research Corp Addition products of halogen and quaternary ammonium germicides and method for making the same
GB2108387B (en) * 1979-12-28 1984-03-21 Green Cross Corp A pharmaceutical composition containing myeloperoxidase
US4473550A (en) * 1981-01-16 1984-09-25 Rosenbaum Robert S Bactericidal compositions and methods
US4473500A (en) * 1981-05-12 1984-09-25 Ciba-Geigy Corporation Monoazo pigments derived from aminophthalimides and substituted acetoacetarylides or 2-hydroxy-3-naphthoylarylides
JPS592686A (ja) * 1982-06-25 1984-01-09 Green Cross Corp:The ミエロペルオキシダ−ゼの粉末製剤
US4588586A (en) * 1983-01-03 1986-05-13 Kessler Jack H Method for disinfecting a contact lens
US4516817A (en) * 1983-04-25 1985-05-14 Deters Paul M Electrical jumper assembly
US4576817A (en) * 1984-06-07 1986-03-18 Laclede Professional Products, Inc. Enzymatic bandages and pads
LU85479A1 (fr) * 1984-07-25 1986-02-12 Oleofina Sa Compositions antibacteriennes de nourriture pour animaux et procede pour les preparer
US4937072A (en) * 1986-05-12 1990-06-26 Kessler Jack H In situ sporicidal disinfectant
DK501686A (da) * 1986-10-20 1988-04-21 Otto Melchior Poulsen Enzymholdigt, baktericidt middel samt tandplejemidler og saarbehandlingsmidler, som indeholder det
US4996146A (en) 1987-02-20 1991-02-26 Kessler Jack H Rapid sterilization enzymatic process with persistence
FR2632525B1 (fr) 1988-06-14 1992-07-31 Improbio Application therapeutique de la myeloperoxydase humaine
WO1990003185A1 (en) * 1988-09-28 1990-04-05 Ideon Corporation Combination enzyme immunotherapeutics
FR2646777B1 (fr) * 1989-05-12 1993-09-03 Bio Serae Lab Procede de preparation d'un produit particulaire antimicrobien, produit antimicrobien obtenu et applications
GB9002422D0 (en) * 1990-02-03 1990-04-04 Boots Co Plc Anti-microbial compositions

Also Published As

Publication number Publication date
CA2061601C (en) 2003-04-08
IL100997A0 (en) 1992-11-15
KR930703012A (ko) 1993-11-29
IL100997A (en) 1996-09-12
DE69233698T2 (de) 2008-02-28
CA2061601A1 (en) 1992-08-22
EP0500387A2 (de) 1992-08-26
EP0500387B1 (de) 1999-07-07
US6294168B1 (en) 2001-09-25
EP0923939B1 (de) 2007-06-20
IE20000984A1 (en) 2001-05-30
JP2004300157A (ja) 2004-10-28
EP0500387A3 (en) 1992-10-28
EP0923939A1 (de) 1999-06-23
WO1992014484A1 (en) 1992-09-03
JPH06505482A (ja) 1994-06-23
ATE365048T1 (de) 2007-07-15
IE920514A1 (en) 1992-08-26
JP4063317B2 (ja) 2008-03-19
DE69229512T2 (de) 2000-03-30
AU1536492A (en) 1992-09-15
DE69233698D1 (de) 2007-08-02
ATE181837T1 (de) 1999-07-15
AU663869B2 (en) 1995-10-26

Similar Documents

Publication Publication Date Title
DE69229512D1 (de) Verfahren und Zusammensetzung mit Haloperoxydase zur Behandlung von Infektionen und Kontrolle der Flora
ATE347277T1 (de) Zusammensetzung mit bakteriostatischen und bakteriziden eigenschaften gegen bakterielle sporen und zellen und verfahren zu deren verwendung zur behandlung von lebensmitteln
MX9806356A (es) Composiciones antimicrobianas sinergisticas que contienen un polimero de ioneno y una sal de dodecilamina y metodos para usar las mismas.
WO1992019104A3 (en) Fatty acid based compositions for the control of established plant infections
DE69533593D1 (de) Zubereitungen zur behandlung von gastrointestinalen störungen, welche arabinogalactan und polyphenole von larix enthalten.
ATE264685T1 (de) Angesäuertes nitrit zur verwendung als antimikrobielles mittel
ATE153648T1 (de) Verwendungen von alpha-hydroxyfettsäuren
ATE188341T1 (de) Konservierungsmittel und verfahren zur behandlung von holz
DE69431056D1 (de) Substituierte oxazolyl-derivate zur behandlung von entzündungen
CA2141803A1 (en) Methods for inactivating bacteria in blood preparations with 8-methoxypsoralen
AU2693397A (en) Antimicrobial peroxidase compositions
SE7608812L (sv) Antiseptiska kompositioner
NZ505742A (en) Compositions containing aminobiguanides with antimicrobial activity used to treat contact lenses
ATE499944T1 (de) Verwendung von einem extrakt von einem nicht- photosynthetischen faserigen bakterium zur beförderung der herstellung von superoxid- dismutase
DE60128860D1 (de) Zusammensetzungen zur Inhibierung der radikal initierten Polymerisation in der Haut und dem Haar
DE68921002T2 (de) Verfahren und mittel zur präventiven behandlung von chirurgischen adhäsionen.
DE60008562D1 (de) Hopfensäuren zur hemmung von staphylococcus aureus
RU96124444A (ru) Биологическая композиция для лечения ран "коллахит"
DE3769497D1 (de) Mittel zur bekaempfung von phytopathogenen mikroben.
DK1092427T3 (da) Anvendelse af et peptid, der forebygger hudintolerancereaktioner, især i kosmetiske præparater
ES2062614T3 (es) Composiciones antimicrobianas sinergicas.
DE69408664D1 (de) Zusammensetzungen zur behandlung von geernteter pflanzenmaterial
WO2023196678A3 (en) 4-phenyl-2-pyrrolidinones and methods of using thereof
JPH07233030A (ja) 髪膚活性剤 樹葉

Legal Events

Date Code Title Description
8363 Opposition against the patent
8331 Complete revocation